RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1007%2F978-3-031-28012-2_22
https://w3id.org/ripe/ripe-kg/work/10.1007%2F978-3-031-28012-2_22
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
prism:doi |
10.1007/978-3-031-28012-2_22 |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
dcterms:title |
Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
node1 |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
rdfs:Resource |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
owl:Thing |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
prov:Entity |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |
owl:sameAs |
https://semopenalex.org/work/W4382344809 |
ripekg:work/10.1186%2Fs13063-025-08916-5Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1007%2F978-3-031-28012-2_22Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 |